C G Rapp

Learn More
Parkinson's disease continues to be a tragic debilitator of close to half a million Americans. As more is learned about the disease, pharmacological treatment improves. Just recently, deprenyl became a part of our therapeutic armamentarium, and it appears that Sinemet CR will soon be following. It is hoped that these drugs will improve the quality and(More)
Behavioral and psychological symptoms of dementia (BPSD) may be framed within the Needs Driven Dementia-Compromised Behavior (NBD) Model. Current literature suggests that BPSD may escalate. Several researchers have described a sequence of behavioral escalation that has a clear starting point and ending point. This 'ideal' or concatenated sequence is used to(More)
Participation in clinical drug trials is becoming a common expectation of many neuroscience nurses. Prior to assuming responsibilities associated with a research study, the roles, rights and responsibilities involved must be thoroughly understood. The effective neuroscience nurse brings to the research arena a thorough knowledge of the drug under study,(More)
  • 1